Swarna Bhasma : The Calcined Gold Formulation of Ayurveda
Swarna Bhasma, the incinerated calx of gold, represents one of the most venerated and potent formulations in the Rasa Shastra tradition of Ayurveda. Gold (Swarna) is classified under the Sara Loha Varga (noble metals) and is considered superior to all other metals in its therapeutic potential . Its transformation into a Bhasma through rigorous pharmaceutical processing converts this precious metal into a safe, bioavailable, and therapeutically potent nano-particulate formulation. The preparation is held in the highest esteem for its Rasayana (rejuvenative), Medhya (nootropic), and Vrishya (aphrodisiac) properties . Almost all ancient Ayurveda classics have indicated the therapeutic utilities of Swarna .
The formulation occupies a unique position as a Yogavahi (synergistic carrier), facilitating the targeted delivery of therapeutic agents to deep tissues. Its nano-particulate nature, resulting from the classical preparation methods, enables unique characteristics including Rasayana (immune regulation and anti-aging), Yogavahi (targeted drug delivery), Alpamatra (efficacy in small doses), Rasibhava (rapid and easy absorption and assimilation), Shigravyapi (quick distribution and rapid action), and Agnideepana (enhancement of cellular metabolism and catalyst-like activity) . Its therapeutic scope extends across internal medicine, neurology, oncology support, and reproductive health.
Its primary therapeutic intentions are:
· To function as a potent Rasayana, promoting longevity, immunity, and tissue regeneration
· To serve as a Medhya (nootropic), enhancing memory, intellect, and cognitive function
· To provide a Balya (strengthening) effect, improving overall physical strength and stamina
· To act as an immunomodulator, enhancing both innate and adaptive immunity
· To exhibit anti-carcinogenic and hepato-protective properties
· To function as an antioxidant, neuroprotective, and anti-inflammatory agent
2. Classical Taxonomy and Properties of Swarna
In Ayurvedic pharmacology, gold is described with a specific pharmacological profile that justifies its broad therapeutic utility.
2.1 General Properties of the Metal
· Rasa (Taste): Madhura (Sweet), Kashaya (Astringent), Tikta (Bitter)
· Guna (Qualities): Guru (Heavy), Snigdha (Unctuous), Sheeta (Cold)
· Virya (Potency): Sheeta (Cold)
· Vipaka (Post-digestive effect): Madhura (Sweet)
· Dosha Karma: Vata-Pitta Shamaka (Pacifies Vata and Pitta)
2.2 Properties and Actions of Swarna Bhasma
The properly prepared Swarna Bhasma is described to possess the following attributes :
· Rasayana: Immunomodulatory, rejuvenative, and anti-aging properties
· Medhya: Enhances intellect, memory, and learning abilities
· Vrishya: Aphrodisiac and promotes reproductive health
· Balya: Improves strength, stamina, and overall physical potential
· Prabha and Kanti Pradam: Improves skin complexion and luster
· Paramlekhana: Scraping of unwanted vitiated tissues
· Hridya: Cardiotonic
· Ayushya: Prolongs young age and promotes longevity
· Deepana: Improves metabolic fire and digestion
3. Preparation Protocol
The preparation of Swarna Bhasma is a rigorous, multi-stage process involving Shodhana (purification), Marana (incineration), and specific techniques to achieve the desired therapeutic quality. The process typically involves Bhavana (trituration with liquid media) and Puta (incineration) with specific temperature patterns.
3.1 Shodhana (Purification) of Swarna
· Principle: The purification process aims to remove impurities and prepare the metal for incineration.
· Procedure: Gold is subjected to heating and quenching in specific liquid media. One classical method involves melting the gold and quenching it in Tila Taila (sesame oil), followed by quenching in Takra (buttermilk), Gomutra (cow urine), Kanji (fermented rice water), and Kulatha Kwatha (decoction of horse gram) .
· Observation: The Nirvapa process produces a dulling effect on the metal and results in a weight loss, signifying the removal of external impurities.
3.2 Marana (Incineration Process)
The incineration of gold is achieved through the Puta system, where the processed metal is subjected to specific heating cycles.
· Ingredients for Marana: Purified gold is triturated with specific liquid media and sometimes with Shuddha Gandhaka (purified sulfur) or Shuddha Hingula (purified cinnabar) . The choice of media influences the final properties of the Bhasma .
· Bhavana (Trituration): The gold is triturated with specific liquid media such as Kumari Swarasa (aloe vera juice), Nimbu Swarasa (lemon juice), or Triphala Kwatha (decoction of three myrobalans) . This process is repeated several times and helps in the absorption of the medicinal properties of these herbs.
· Puta (Incineration): The triturated material is formed into pellets and placed in an earthen pot crucible (Sarava Samputa). This is subjected to Puta incineration using a specific number of cow dung cakes. The temperature and duration of the Puta are carefully controlled. The process may be repeated several times until the characteristic qualities of a proper Bhasma are achieved .
· Alternative Method: Some classical methods involve the Kupipakwa procedure, where the material is heated in a glass bottle placed in a Valuka Yantra (sand bath) .
3.3 Quality Assessment (Bhasma Pariksha)
After preparation, the Bhasma must pass a series of classical tests to confirm its proper incineration and safety .
· Rekhapurnata: The fine powder should enter the furrows of the fingers when rubbed, indicating proper fineness.
· Varitara: The Bhasma should float on the surface of still water, indicating lightness.
· Unama: The Bhasma should remain floating even when a rice grain is placed on it.
· Nirdhuma: The Bhasma should not emit any fumes when exposed to fire.
· Niswadu: The Bhasma should not possess any taste.
· Nishchandrata: The Bhasma should be free from any residual shining particles of the original metal.
· Apunarbhava: The Bhasma should not regain its original metallic luster when heated.
· Niruttha: When the Bhasma is treated with a silver leaf, the weight of the silver should not increase, indicating complete incineration.
· Amla Pariksha: The color of curd should not change when mixed with the Bhasma, indicating the absence of unconverted metal.
4. Physico-Chemical and Analytical Profile
Modern analytical techniques have elucidated the structural and chemical nature of Swarna Bhasma, validating its nano-crystalline form and complex composition.
4.1 Particle Size and Structure
· Nanoscale Nature: Swarna Bhasma consists of particles in the nanometer range, which is a key factor in its enhanced bioavailability and therapeutic potency. Studies have reported an average particle size of 7.67 nm for Swarna Bhasma, with spherical and oval-shaped particles . Other studies have reported crystallite sizes of 23-37 nm and globular particles with an average size of 56-57 nm .
· Structural Components: The nanoparticles in Swarna Bhasma are composed of pure gold, with the gold content ranging from 62.6% to 98% in different preparations . The variation in gold content and particle size can arise from differences in the source of raw material and the specific Ayurvedic procedures followed .
· Surface Coating: The nanoparticles are enveloped with a corona of trace elements and organic matter from the herbal media used during Bhavana . This Bhasma nanoparticle (BNP) with its nanocrystalline metallic core and resplendent corona is a key feature that contributes to its biocompatibility and therapeutic properties .
4.2 Elemental Composition
· Gold Content: ICP-AES and ICP-MS studies have revealed that Swarna Bhasma contains 90-98% pure gold .
· Trace Elements: Other elements reported in Swarna Bhasma include calcium (0.7%) and magnesium (0.2%) .
4.3 Functional Group Analysis (FTIR)
· Presence of Organic Matter: FTIR analysis of Swarna Bhasma has yielded varying results. Some studies suggest that Swarna Bhasma does not have any organic matter , while others indicate the presence of organic compounds from the herbal media used during preparation. The presence of these functional groups confirms that the Bhasma is a herbometallic complex, where the metal is associated with organic compounds, contributing to its biological activity.
4.4 Safety Profile
· Non-Toxic at Therapeutic Doses: Swarna Bhasma has been found to be biocompatible with blood cells and did not result in blood cell aggregation or protein adsorption . Animal studies have shown that it does not have any adverse effects up to a dose of 13.5 mg/kg body weight . Histopathological studies after 90 days of oral administration showed no change in tissue morphology .
· No Cytotoxicity: The Bhasma particles were not cytotoxic against Caco-2 cell lines .
5. Pharmacological Properties and Documented Benefits
5.1 Anti-Carcinogenic Activity
Recent research has unveiled the potent anti-carcinogenic properties of Swarna Bhasma. A study on Ehrlich's Ascites Carcinoma (EAC) mice model demonstrated that Swarna Bhasma exhibited dose-dependent anti-carcinogenic activity :
· Reduction in Tumor Markers: Swarna Bhasma at higher doses (7.8 mg/kg body weight) significantly reduced the levels of Carcinoembryonic Antigen (CEA), Tumor Necrosis Factor-alpha (TNF-α), and Interleukin-6 (IL-6), which are key markers of tumor progression and inflammation.
· Medium Dose Efficacy: At a medium dose (3.9 mg/kg body weight), Swarna Bhasma helped in reducing IL-6 levels, suggesting its mild anti-carcinogenic potential.
· Hepato-Protective Effect: At a low dose (1.95 mg/kg body weight), Swarna Bhasma showed no anti-carcinogenic effect but helped in promoting hepatic functions against the disease, as evidenced by a dose-dependent reduction in the AST/ALT ratio.
· Reduction in Tumour Volume: A significant reduction in tumor volume was reported in both the moderate and high dose groups, along with marked improvement in anorexia.
· Mechanism: The nanoparticles derived from Swarna Bhasma possess distinctive physicochemical properties, including surface plasmon resonance and selective binding ability to amine and sulfhydryl groups. They passively accumulate within tumor sites through the Enhanced Permeability and Retention (EPR) effect, taking advantage of the leaky vasculature of tumors.
5.2 Immunomodulation
Swarna Bhasma is recognized for its potent immunomodulatory properties:
· Macrophage Function: Studies have reported that Swarna Bhasma shows an immunostimulant activity on macrophage functions in the mouse model .
· Immunity Enhancement: It is widely used to enhance the body's immunity to fight against infections . It has been reported to augment non-specific immunity in mice .
· Rasayana Action: Its Rasayana property translates to immune regulation and anti-aging effects .
5.3 Neuropharmacological and Cognitive Enhancement
Swarna Bhasma is a well-established Medhya Rasayana, indicating its profound impact on cognitive function and mental health:
· Anti-Anxiety and Antidepressant: Studies have shown that Swarna Bhasma has anxiolytic, antidepressant, and anticataleptic effects in rats and mice .
· Memory Enhancement: It has shown significant effects on memory enhancing and improving learning abilities . It has demonstrated neuroprotective efficacy against sleep deprivation-induced cognitive impairment in rats .
· Neurotransmitter Modulation: Swarna Bhasma has been found to reduce stress-induced alteration of several neurotransmitters such as dopamine, epinephrine, norepinephrine, 5-HT, and corticosterone .
5.4 Antioxidant Activity
· Free Radical Scavenging: Swarna Bhasma has demonstrated antioxidant effects in various models, including against ischemia in the rat model . It helped restore the alteration in enzymatic parameters such as reduced glutathione, glutathione reductase, glutathione-S-transferase, lipid peroxidase, catalase, superoxide dismutase, and glucose-6-phosphate dehydrogenase due to ischemia .
· Oxidative Stress Reduction: It helps clear excess free radicals .
5.5 Analgesic and Anti-Inflammatory Activity
· Pain Relief: Animal studies have suggested that Swarna Bhasma has analgesic properties .
· Inflammation Reduction: Swarna Bhasma has been shown to reduce inflammation in various conditions, including arthritis .
5.6 Reproductive Health
· Reproductive Function: Studies have shown that Swarna Bhasma treatment modulated D-galactose-induced reproductive alterations in male Wistar rats . Gold has also been shown to stimulate reproductive function in immature female albino rats .
· Vrishya Action: Its classical reputation as an aphrodisiac is supported by research demonstrating its role in supporting reproductive function.
6. Therapeutic Applications and Clinical Indications
6.1 Classical Indications
· Chronic diseases and general debility
· Neurological disorders including convulsions, insomnia, and cognitive decline
· Mental disorders including anxiety and depression
· Anemia and metabolic disorders
· Skin diseases
· Diabetes mellitus syndrome, where formulations like Vasantakusumakara Rasa are prescribed
· As a Rasayana for rejuvenation and longevity
· As a Medhya for intellectual enhancement
6.2 Contemporary Indications
· Cancer support care (as an adjunct therapy)
· Immunodeficiency and recurrent infections
· Arthritis and inflammatory conditions
· Cardiovascular disorders (as a cardiotonic)
· Neurodegenerative diseases
· Reproductive health and infertility
· Stress-related disorders
7. Dosage, Administration, and Formulations
Standard Therapeutic Dose: 20 mg to 125 mg per day, typically taken in divided doses as prescribed by an Ayurvedic physician . The dose ranges from 20 mg to 50 mg twice daily or 125 mg to 250 mg twice daily depending on the specific condition and the physician's recommendation .
Timing and Anupana (Vehicle):
· Anupana: The Bhasma is commonly administered with specific Anupanas (vehicles) to enhance its absorption and action. Commonly used vehicles include honey, cow's ghee, milk, or a combination of these . The choice of Anupana is determined based on the disease condition and the patient's constitution.
· Timing: It is generally taken on an empty stomach, often in the early morning, or as prescribed by the physician.
Key Formulations:
· Swarna Prashana: A preparation containing Swarna Bhasma that is used to enhance memory, growth, and promote longevity in children aged between 0-16 years .
· Raupya Suvarna Sutashekhar Rasa: A compound formulation containing Swarna Bhasma and other ingredients, used for its immunomodulatory, nootropic, and anti-inflammatory properties .
· Vasantakusumakara Rasa: A formulation containing Swarna Bhasma, used for diabetes mellitus syndrome .
· Other Compound Formulations: Swarna Bhasma is an ingredient in numerous other Rasayana and therapeutic formulations.
8. Contraindications and Precautions
Expected Responses and Mild Reactions:
· None reported at standard therapeutic doses. Clinical and experimental studies have consistently shown that Swarna Bhasma is safe and non-toxic at standard therapeutic equivalent doses when properly prepared .
Specific Contraindications:
· Improperly Prepared Bhasma: The most significant risk is from impure or improperly prepared Bhasma that has not been adequately incinerated. The Bhasma must pass standard classical tests like Varitara (floating on water) and Nishchandratva (loss of metallic luster) to be safe for internal use.
· Self-Medication: It must only be taken under the strict supervision of a qualified Ayurvedic physician trained in Rasa Shastra. Dosage and duration must be accurately prescribed based on the patient's constitution and condition.
· Pregnancy and Lactation: Caution is advised, and use should be limited to conditions where the benefits clearly outweigh the risks, under strict medical supervision. It is generally advised to avoid using Swarna Bhasma during pregnancy unless specifically indicated .
· Other Medical Conditions: It is advised to consult an Ayurvedic physician before using Swarna Bhasma for any medical condition .
Drug Interactions:
· Information on specific drug interactions is limited. However, as a potent Rasayana and metabolic modulator, it should be used with caution alongside other potent medications. It is always advisable to inform the physician of all concurrent medications.
9. Professional Supervision and Scope of Use
Swarna Bhasma is a potent herbometallic drug whose preparation and administration require the direct supervision of a qualified Vaidya (Ayurvedic physician) with expertise in Rasa Shastra. The physician will:
1. Prakriti Assessment (Constitutional Type): Determine the patient's constitution to assess the suitability of Swarna Bhasma and the most appropriate Anupana.
2. Vikriti Assessment (Current Imbalance): Identify the specific condition and determine the appropriate therapeutic formulation, dose, and duration.
3. Agni Assessment (Digestive Strength): Ensure the patient's digestive capacity is adequate to metabolize the Bhasma.
4. Quality Control: Ensure the Bhasma being administered has been prepared according to classical standards and has passed all the required quality tests.
5. Monitoring: Closely monitor the patient for any adverse effects and manage them promptly.
Swarna Bhasma is not a standalone cure for serious diseases like cancer. Its role is as a powerful Rasayana and systemic modulator that supports the body's natural healing mechanisms. It must be used within a properly supervised, multimodal treatment framework that includes dietary modifications, lifestyle changes, and other Ayurvedic or conventional medical interventions. It should not be used to delay or replace evidence-based medical treatment when such treatment is indicated.
-x-x-
This monograph was prepared by synthesizing classical Ayurvedic principles from Rasa Tarangini, Charaka Samhita, and other primary texts with peer-reviewed modern research, including a synoptic review on Swarna Bhasma's origin, pharmaceutical, analytical, and pharmacological studies (Rani et al., IJAR, 2024), an experimental study on its anti-carcinogenic properties in an EAC mice model (JAIM, 2025), a characterization and bioavailability study of Swarna Bhasma (Shodhganga thesis), and research on its physicochemical characterization, safety profiling, and pharmacological activities (Biswas et al., J Ethnopharmacol, 2020; Bajaj and Vohora, Indian J Pharmacol, 2000; Shah and Vohora, Pharmacol Toxicol, 2002).

Comments